“It should be noted that there was still a numeric advantage of the combo compared with stopping methotrexate and maintaining tocilizumab [in these patients],” he says.
You Might Also Like
Explore This IssueOctober 2018
Also By This Author
Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.
ad goes here:advert-1
SCROLL TO CONTINUE
- Kremer JM, Rigby W, Singer NG, et al. Sustained response following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: Results from a randomized, controlled trial. Arthritis Rheumatol. 2018 Aug; 70(8):1200–1208.